Dusquetide Technology Platform to be Presented at the 2017 Drug Discovery and Therapy World Congress
ABC 7 News KSWO,
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX ) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: ) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
PRINCETON, N.J., July 6, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
PRINCETON, N.J., Feb. 4, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a development-stage…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
Information contained on this page is provided by an independent third-party content provider.
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX ) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
SOURCE Soligenix, Inc. PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
PRINCETON, N.J. SGX942 is the drug product using dusquetide, an Innate Defense Regulator, for the treatment of oral mucositis.
PRINCETON, N.J., June 19, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
SOURCE Soligenix, Inc. At 12 Months SGX942 Found to be Safe and Well Tolerated with Multiple Potential Ancillary Benefits…
SOURCE Soligenix, Inc. At 12 Months SGX942 Found to be Safe and Well Tolerated with Multiple Potential Ancillary Benefits…
SOURCE Soligenix, Inc. At 12 Months SGX942 Found to be Safe and Well Tolerated with Multiple Potential Ancillary Benefits…
SOURCE Soligenix, Inc. At 12 Months SGX942 Found to be Safe and Well Tolerated with Multiple Potential Ancillary Benefits…
SOURCE Soligenix, Inc. At 12 Months SGX942 Found to be Safe and Well Tolerated with Multiple Potential Ancillary Benefits…
SOURCE Soligenix, Inc. At 12 Months SGX942 Found to be Safe and Well Tolerated with Multiple Potential Ancillary Benefits…